Concerning BRAF-mutated melanoma with low TILs, the optimal therapeutic strategy should be sought, as BRAF inhibition can have immunomodulatory effects by increasing the number of TILs or reprogramming them.51 This evidence concerns the gene BRAF and melanoma.